Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Entest Group, Inc. (ETNI)
Shenzhen, CN
Entest Group, Inc. currently lacks substantial active business operations. Its primary objective is to identify, scrutinize, and analyze potential business ventures, with the aim of achieving a merger, acquisition, or other form of business consolidation with an existing operating company. Founded in 2008 and based in Shenzhen, China, the company adopted its current name in February 2018, having previously operated as Entest Biomedical, Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -80.00% | +0.00% | -98.40% | -95.74% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+105.3% ★ Q4'19: -110.0% (vs Q4'18)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q4'19: +142.2% (vs Q4'18)
-
Share dilution Shell Companies: -10.2%+0.4% ★ Q4'19: +0.0% (vs Q4'18)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×0.11×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (82-3143794) | 2.50M | 5.08% | 2.50M | 2.50M | 2.50M | 2.50M | CO | Wyoming, USA | 2018-01-31 | ↗ |
| 2 | Southridge Partners II LP | 10.00 | 12.00% | 2.33M | 2.33M | 2.33M | 2.33M | PN | Delaware | 2012-03-22 | ↗ |
| 3 | of the Act (however, see the Notes). | 10.00 | 9.20% | 41.05M | 41.05M | 41.05M | 41.05M | PN | Pennsylvania, USA | 2013-03-25 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Lin | Director of Research and Member of Advisory Board | — | — |
| Peiwen Yu | President, Chief Executive Officer & Director | — | male |
| Steven Josephs | Chief Science Officer and Member of Advisory Board | — | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ETNI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
